On the one hand, HCV infection triggers diabetes, mostly type 2 but occasionally (especially in patients treated with IFNα) type 1 diabetes; and, on the other hand, diabetes worsens hepatitis C outcomes, including increasing the risk for cirrhosis and HCC. This evidence concerns the gene IFNA1 and diabetes mellitus.